Reuters logo
BRIEF-Regeneron says Q4 U.S. Eylea sales about $400 mln
January 14, 2014 / 4:00 PM / 4 years ago

BRIEF-Regeneron says Q4 U.S. Eylea sales about $400 mln

Jan 14 (Reuters) - Regeneron Pharmaceuticals Inc : * Says Q4 U.S. Eylea sales about $400 million * CEO says 2013 U.S. Eylea sales about $1.4 billion * CEO says quite a bit of room for Eylea growth * Says Sanofi to spend about $1 billion on Regeneron pipeline in 2014

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below